Navigation Links

Biology Technology

AxioMed Energized by Publication Showing Success of Outpatient Cervical Disc Replacements

2/24/2017
Malden, MA (PRWEB) February 24, 2017 A study recently published in Spine shows total disc replacement (TDR) procedures can be safely completed in an ambulatory surgery center (ASC) with satisfactory clinical and patient-reported outcomes, when compared to anterior cervical discectomy and fusi... [Comments]

Delpor Awarded NIH Grant for 3-month Olanzapine Implant for the Treatment of Schizophrenia

2/24/2017
SAN FRANCISCO, CA (PRWEB) February 24, 2017 Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, today announced the awarding of a $224K grant from the National Institute of Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( DLP-... [Comments]

Lajollacooks4u Explores Food and Wine Scene Around South Africa

2/24/2017
San Diego, Calif. (PRWEB) February 24, 2017 Chef Jodi Abel has returned from her three-week tour through the South African food and wine scene. Making stops in several cities, she gained a number of delicious recipes and new techniques to share with her Lajollacooks4u guests. Her culinar... [Comments]

Provectus Biopharmaceuticals Provides Information On Rights Offering Deadline

2/24/2017
KNOXVILLE, Tenn. , Feb. 24, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com ) ("Provectus" or the "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, today is providing additional information regarding the deadline to participate in its previously announced rights offering of up to 19 million units, consisting of shares... [Comments]

Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism

2/24/2017
SAN DIEGO , Feb. 24, 2017  Aethlon Medical, Inc. (Nasdaq: AEMD ), today released the following note authored by its Chairman and CEO, Jim Joyce . In a chilling address at the Munich Security Conference last Saturday, Bill Gates warned world leaders that a genetically engineered virus could kill more people than nuclear weapons. Mr. Gates expressed his concern, which... [Comments]

Symic Bio Announces Last Patient Enrolled in SHIELD Trial of SB-030 for Interventions in Peripheral Artery Disease

2/24/2017
SAN FRANCISCO , Feb. 24, 2017 Symic Bio, a biopharmaceutical company focused on matrix biology that is developing a new category of therapeutics, announced today the completion of enrollment for the SHIELD clinical trial of SB-030 in peripheral artery disease. The trial will evaluate the safety and efficacy of SB-030, a locally administered single-use therapeutic, in the reduc... [Comments]

Natural Trends, Anti-pollution Protection Claims, and New Technologies are the Cornerstones of the Specialty Actives Market's Strong Growth, Finds Kline

2/24/2017
PARSIPPANY, N.J. , Feb. 24, 2017  Driven by consumers' preference towards more natural products, botanicals and biotechnology are now the fastest growing categories, finds the recently published U.S. volume from the Specialty Actives in Personal Care: Multi-regional Market Analysis and Opportunities study by global market research and management consulting firm Kline.... [Comments]

China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2017

2/24/2017
HONG KONG, Feb. 24, 2017 China Cord Blood Corporation (NYSE: CO ) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the third quarter and first nine months of fiscal year 2017 ended December 31, 2016. Third... [Comments]

FireflySci USA Expands Spectrophotometer Calibration Standard Network to Canada

2/24/2017
Staten Island, NY (PRWEB) February 24, 2017 FireflySci, Inc is an explosive small business that continues to grow at an exponential rate. Founded in late 2014, FireflySci had the goal of bringing their powerful cuvette and spectrophotometer calibration to the spectroscopy world. Now in 20... [Comments]

China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016

2/24/2017
BEIJING, Feb. 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the fourth quarter and fiscal year of 2016. Fourth Quarter 2016 Financial Highlights Total sales in the fourth quarter of 2016 increased by 21.7% in RMB... [Comments]

VWR Corporation Reports Fourth Quarter 2016 Financial Results

2/24/2017
RADNOR, Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, today reported its financial results for the fourth quarter and full year ended December 31, 2016. Highlights: 4Q16 record quarterly net sales of $1.13 billion, up 1.6% year-over-year, and up 1.0% on... [Comments]

Medicine Technology

exocad America and Biodenta Announce Path to Compliance

2/24/2017
WOBURN, Mass. , Feb. 24, 2017  Today, exocad America and the Biodenta Group announce that US dental labs have a new path to produce 510(K) cleared, in-house milled, custom dental abutments using the Biodenta implant library integrated into exocad DentalCAD software. In order to achieve this, labs must implement FDA compliant Good Manufacturing Processes (GMP's) into their... [Comments]

E-QURE's BST Device for Chronic Wound Care Receives Marketing Approval in Israel

2/24/2017
NEW YORK , February 24, 2017 Following receiving CE Marking in Europe , Israel ' s AMAR is a major milestone for the country where the device was developed   $ 250 M w ound care market in Israel   E-QURE file s BST for inclusion in the National Health Basket , Israel ' s national healthcare reimbursement s... [Comments]

Global $330.5 Billion Wireless Health Market Analysis & Trends 2013-2017 - Industry Forecast to 2025 - Research and Markets

2/24/2017
DUBLIN , Feb. 24, 2017 Research and Markets has announced the addition of the "Global Wireless Health Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Wireless Health Market is poised to grow at a CAGR of around 23.8% over the next decade to reach approximately $330.5 billion by 2025. This industry report... [Comments]

Zimmer Biomet Holdings to Present at the Cowen and Company 37th Annual Health Care Conference

2/24/2017
WARSAW, Ind. , Feb. 24, 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will present at the Cowen and Company 37 th Annual Health Care Conference at the Boston Marriott Copley Place on Tuesday, March 7, 2017 at 11:20 a.m. Eastern Time. A live webcast of the presentation can be accessed at http://wsw.com/webcast/cowen38... [Comments]

Global $2.9 Billion Empty Capsules Market Analysis & Trends 2013-2017 & Industry Forecast to 2025: Increasing Demand for Empty Capsules in Nutraceutical Industry - Research and Markets

2/24/2017
DUBLIN , Feb. 24, 2017 Research and Markets has announced the addition of the "Global Empty Capsules Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Empty Capsules Market is poised to grow at a CAGR of around 8.6% over the next decade to reach approximately $2.9 billion by 2025. This industry report anal... [Comments]

Hemophilia Drugs Price Analysis and Strategies 2012-2016 & 2016-2021: How the Price Advanced from 2012 and Forecasts to 2021 - Research-and-Markets

2/24/2017
DUBLIN , Feb 24, 2017 Research and Markets has announced the addition of the "Hemophilia Drugs Price Analysis and Strategies - 2016" report to their offering. The latest research Hemophilia Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Hemophilia market. The research answers the following questions:... [Comments]

Dry Eye Drugs Price Analysis and Strategies 2012-2021: Identify How Drugs are Clinically and Commercially Positioned - Research and Markets

2/24/2017
DUBLIN , Feb 24, 2017 Research and Markets has announced the addition of the "Dry eye Drugs Price Analysis and Strategies - 2016" report to their offering. The latest research Dry eye Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Dry eye market. The research answers the following questions: Wha... [Comments]

Wolf Administration Officials, Overdose Survivor Commend Pennsylvania EMS Providers for Using Narcan to Save Lives

2/24/2017
HARRISBURG, Pa. , Feb. 24, 2017 Physician General Dr. Rachel Levine and Acting Secretary of Drug and Alcohol Programs Jennifer Smith commended South Central EMS today for their active role in providing training for and using naloxone, a life-saving overdose reversal drug. The recognition event also featured Mark McCullough , a recovery specialist and overdose s... [Comments]

DURECT Corporation Invites You to Join its Fourth Quarter 2016 Earnings Conference Call

2/24/2017
CUPERTINO, Calif. , Feb. 24, 2017  In conjunction with DURECT Corporation's (Nasdaq: DRRX ) fourth quarter 2016 financial results press release, you are invited to listen to a conference call that will be broadcast live over the internet on Tuesday, March 14, 2017 at 4:30 pm Eastern Time (1:30 pm Pacific Time). A live audio webcast of the presentation will be available... [Comments]

New Study Highlights Strategies for Developing Strong Medical Information Groups in Pharmaceutical Companies

2/24/2017
CHAPEL HILL, N.C. , Feb. 24, 2017 Medical information groups within the pharmaceutical sector are exploring ways to increase their self-service capabilities to manage inquiries from external stakeholders such as Health Care Providers (HCPs). New research from consulting leader Best Practices, LLC found that many pharma organizations have developed self-service website portal... [Comments]

URGENT: Monteverde & Associates PC Invites Inotek Pharmaceuticals Corporation Shareholders with Losses To Contact The Firm Immediately - ITEK

2/24/2017
NEW YORK , Feb. 24, 2017 Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New York City , announces that a class action lawsuit has been filed in the U.S. District of Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek... [Comments]

(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain ... for adults at home or in healthcare facilities during periods of rest. A ...
(Date:2/23/2017)... ... February 23, 2017 , ... Today, researchers can fast-track ... uric acid, and/or other biomarkers or SNPs of interest) using one, easy-to-collect saliva ... , the relationship between insulin and other relevant biomarkers can be extensively studied ...
(Date:2/23/2017)... , Feb. 23, 2017 Aviva Systems ... announced the acquisition of GenWay Biotech Incorporated, a ... service and product offering for both the research ... facilitate growth and enhance capabilities for both entities. GenWay,s ... ELISA assays will nicely complement ASB,s objective to ...
(Date:2/22/2017)... 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics ... biopharmaceutical products for companion animals, will host a live conference ... to discuss financial results from the fourth quarter and full ... and investors may access the audio webcast or ... ...
Breaking Biology Technology:
(Date:2/23/2017)... Feb. 23, 2017 Nevro Corp. (NYSE: NVRO), a ... for the treatment of chronic pain, today reported financial results ... 2016. 2016 Accomplishment & Highlights: ... 2016, an increase of 228% as reported, over the prior ... an increase of 612% over the prior year ...
(Date:2/23/2017)... GUIYANG, China , 23. Februar 2017 ... Area , eine nationale Wirtschaftszone in der südwestlichen chinesischen Provinz ... Beschleunigung der Errichtung einer Innovationsplattform aktiv an der Entwicklung einer ... Continue Reading ... ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... to their offering. ... The latest research Fibromyalgia Drugs Price Analysis and Strategies - ... market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Fibromyalgia ...
Breaking Medicine Technology: